Document Detail


Treatment of suction termination of pregnancy-retained products with misoprostol markedly reduces the repeat operation rate.
MedLine Citation:
PMID:  19780743     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A six-year audit of clinical outcomes following the treatment of suction termination of pregnancy-retained products of conception symptoms with 200 microg of misoprostol orally or sublingually three times a day for six doses showed that it was 93% effective and it reduced the repeat dilation and curettage rate by 79.6% (P < 0.001).
Authors:
Dennis G Chambers; Ea C Mulligan
Related Documents :
2797643 - Outpatient therapeutic abortion with mifepristone.
11417023 - Is current practice around late termination of pregnancy eugenic and discriminatory? ma...
17996633 - Pharmacology of antiepileptic drugs during pregnancy and lactation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  49     ISSN:  1479-828X     ISO Abbreviation:  Aust N Z J Obstet Gynaecol     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-09-28     Completed Date:  2010-01-18     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  551-3     Citation Subset:  IM    
Affiliation:
The Queen Elizabeth Hospital Pregnancy Advisory Centre, Woodville Park, Adelaide, 21 Belmore Terrace, Woodville Park, SA 5011, Australia. dennis.chambers@health.sa.gov.sa
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / administration & dosage*
Abortion, Induced / adverse effects*
Administration, Sublingual
Female
Humans
Misoprostol / administration & dosage*
Patient Satisfaction
Pregnancy
Retrospective Studies
Treatment Failure
Vacuum Curettage / adverse effects*
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59122-46-2/Misoprostol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of elevated serum estradiol levels on the day of human chorionic gonadotropin injection o...
Next Document:  The obstructed hemivagina, ipsilateral renal anomaly, uterus didelphys triad.